The FDA's review, which appears in the July 10 issue of the Journal of the National Cancer Institute, refutes numerous studies which have pointed to a link between ingesting lycopene and cutting cancer risk.

The "analysis found no credible evidence that lycopene, either in food or in a dietary supplement, was associated with reduced risk of any of the cancers evaluated," according to chief researcher Claudine Kavanaugh.